Dezhan Healthcare (000813.SZ) joint venture company Dongfang Lue cooperates in research and development of new indications and has obtained clinical trial approval.

22/09/2024

GMT Eight

Dezhan Healthcare (000813.SZ) announced that the company recently received a notification from its investee company, Beijing Oriental Strategic Biotechnology Co., Ltd. (referred to as "Oriental Strategic"), regarding the approval of a Clinical Trial Approval Notice issued by the National Medical Products Administration (NMPA) for their joint project with Inovio Pharmaceuticals, Inc. (referred to as "Inovio") on the VGX-3100 project targeting HPV-16/18 related anal precancerous lesions for Phase II clinical trials.

Zhejiang Communications Technology (002061.SZ) proposes to issue shares to the original shareholders and the authorized period will expire and become invalid.

Ningbo David Medical Device (300314.SZ) founder, controlling shareholder, and one of the actual controllers Chen Yunqin passed away.

Contact: contact@gmteight.com

Dezhan Healthcare (000813.SZ) joint venture company Dongfang Lue cooperates in research and development of new indications and has obtained clinical trial approval.

RECOMMEND

BRIGHT CULTURE (01859): Wang Dao Tie resigns as non-executive director and member of the audit committee.

The first batch of Nezha X was delivered in Hong Kong, and Nezha Motors' overseas expansion strategy is accelerating.

The demand for terminal in the heavy truck industry is still in a waiting period.